Receive $25,000 in member benefits

Oncology Research International Ltd

Oncology Research International Ltd Logo

Investigate, develop new, effective & low cost plant-derived immune-oncology therapies for treatment of cancer 



Year Founded

Not Specified

Company Size

Not Specified

Jobs Available

No Open Positions

Funding Raised

Not Specified


Not Specified


Not Specified


Not Specified


Not an alumni

About Oncology Research International Ltd

ORIL is a public-unlisted biotech start-up headquartered in Adelaide, Australia;
Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach;
Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses

Founders & Key People

Philip Marshall


Share This Profile

Related Profiles

SlyRide Inc

Smart media platform


Fasolid is a leading manufacturer of security screens. Our primary goal is to provide you with top quality security screen products at best prices possible.

Brij Maurya

Founder of

Agilitics Pte. Ltd.

Agilitics Pte. Ltd. is a reknowned Big Data Analytics firm headquartered in Singapore with opernations in mulitple countries. They are expert of big data and belive and spreading the knowledging for betterment of the Big Data community and generating bigger and better talent pool for industry.


Connect Investors to People with World Changing Ideas


Online plant nursery

BEAMSTART brings you the latest news, jobs, and events from all around the world on startups, technology, and business. Stay updated with industry news, plug-in to exciting events, and discover incredible career opportunities with the world's most innovative companies.

© Copyright 2022 BEAMSTART. All Rights Reserved.